WC
NVO

Whitnell & Co’s Novo Nordisk NVO Stock Holding History

Whitnell & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-210
Closed -$5K – 310
2018
Q2 		$5K Hold
210
– – ﹤0.01% 263
2018
Q1 		$5K Hold
210
– – ﹤0.01% 291
2017
Q4 		$6K Buy
+210
New +$5.34K ﹤0.01% 246
2017
Q1 		– Sell
-538
Closed -$10K – 324
2016
Q4 		$10K Buy
+538
New +$9.75K ﹤0.01% 251
2016
Q3 		– Sell
-392
Closed -$11K – 381
2016
Q2 		$11K Sell
392
-140
-26% -$3.84K ﹤0.01% 241
2016
Q1 		$14K Sell
532
-16
-3% -$429 0.01% 219
2015
Q4 		$16K Hold
548
– – 0.01% 223
2015
Q3 		$15K Buy
+548
New +$15.5K 0.01% 217

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Whitnell & Co's NVO Position: Q3 2018 in Review

Whitnell & Co sold out of Novo Nordisk (NVO) in Q3 2018, closing a stake of 210 shares — an estimated $5K sold.

Whitnell & Co first reported a position in NVO in Q3 2015 and held it in 8 quarters. The position peaked at $16K in Q4 2015. 557 funds tracked by Wall St. Rank hold NVO as of Q3 2018.

  • Whitnell & Co reported no remaining Novo Nordisk position as of Q3 2018 after selling out during the quarter.
  • Whitnell & Co sold 210 Novo Nordisk shares in Q3 2018, an estimated $5K.
  • Whitnell & Co first reported a position in Novo Nordisk in Q3 2015 and held it in 8 quarters.
  • Whitnell & Co's Novo Nordisk position peaked at $16K in Q4 2015.
  • 557 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2018.

Based on Whitnell & Co's 13F filing for Q3 2018, filed 23 Oct 2018.